BAM-15 50mg/mL 30mL
High-Concentration BAM-15 for Advanced Mitochondrial Uncoupling Research
The 50mg/mL BAM-15 formulation provides higher concentration for researchers studying dose-dependent mitochondrial uncoupling and fat oxidation effects.
High-Concentration BAM-15 for Advanced Mitochondrial Uncoupling Research
Higher concentration BAM-15 enabling dose-response studies across a broader concentration range for mitochondrial uncoupling and metabolic research.
As one of the most studied compounds in the metabolic & fat loss research space, BAM-15 has attracted sustained scientific interest across Dose-response mitochondrial studies, Advanced uncoupling research. Peer-reviewed evidence indicates that higher concentration for dose-response studies, which has positioned BAM-15 as a reference standard for researchers exploring dose-response mitochondrial studies outcomes. The compound's selectivity and documented tolerability in preclinical models have contributed to a rapidly growing body of literature over the past decade.
BAM-15 Documented Benefits: 1 Documented Mechanisms
Higher Concentration
Enables broader dose-response studies at lower injection volumes.
How BAM-15 Works: Molecular Mechanism & Pathway
Same mitochondrial proton carrier uncoupling mechanism at higher concentration.
The 1 primary research pathways identified for BAM-15 — Higher Concentration — collectively point to a compound with pleiotropic activity across interconnected biological systems. Studies have further shown that same BAM-15 safety profile, reinforcing the mechanistic picture established in earlier cell-line work. Unlike single-pathway agents, BAM-15's broad receptor engagement profile continues to generate hypotheses for novel applications beyond its originally characterized use cases.
Research Protocols & Compound Combinations
BAM-15 is routinely studied alongside MOTS-c and AICAR in metabolic & fat loss-focused compound panels. Researchers investigating dose-response mitochondrial studies have found that pairing compounds with complementary receptor profiles can produce additive results while keeping individual doses within well-characterized ranges. Preliminary evidence that 98.5% purity has informed several of these multi-compound protocol designs.
Purity, Testing & Research Grade Standards
All BAM-15 research material offered through this catalog is manufactured under controlled conditions and independently verified by a third-party laboratory prior to release. Each lot undergoes High-Performance Liquid Chromatography (HPLC) analysis to confirm ≥98% purity, with identity confirmed via mass spectrometry. The accompanying Certificate of Analysis (CoA) documents the exact purity, molecular weight confirmation, and lot-specific testing date — data that should accompany any reproducible research protocol. Lyophilized powder formulation ensures maximum stability during shipping and storage at −20°C long-term or 4°C for short-term use.
◈ Key Highlights
- Higher concentration for dose-response studies
- Same BAM-15 safety profile
- 98.5% purity
Ideal For
- Dose-response mitochondrial studies
- Advanced uncoupling research
Intended for laboratory use only. Not for human or animal consumption. Not FDA approved. Handle in appropriate lab settings only.
What the Research Shows
The following data points are derived from peer-reviewed preclinical and clinical studies on BAM-15. All studies cited in compound profiles are indexed in PubMed or published in peer-reviewed journals.
Higher concentration for dose-response studies
Same BAM-15 safety profile
98.5% purity
Third-Party Verified Every Batch
Each vial of BAM-15 is independently tested by a third-party laboratory before fulfillment. You receive the actual CoA (Certificate of Analysis) documentation with your order.
